Sensorion to Present at the Gene Therapy Neurological Disorders Europe, CASSS Bioassays Symposium an
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News:Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, is pleased to announce the participation of member...